[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kovalik et al., 2012 - Google Patents

Successful treatment of idiopathic sebaceous adenitis in a lionhead rabbit

Kovalik et al., 2012

Document ID
9506782368705696033
Author
Kovalik M
Thoday K
Eatwell K
van den Broek A
Publication year
Publication venue
Journal of exotic pet medicine

External Links

Snippet

A 15-month-old, ovariohysterectomized female Lionhead rabbit was presented with generalized chronic exfoliative dermatitis and patchy alopecia. General physical examination revealed no abnormalities apart from a body condition score of 4 of 9 …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A61K47/08Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30Macromolecular compounds
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Christian et al. The toxicity profile of hydrolyzed aqueous olive pulp extract
Veenstra et al. Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy
Panigrahi et al. Concurrent infestation of Notoedres, Sarcoptic and Psoroptic acariosis in rabbit and its management
Baldwin et al. Results of a phase 2 efficacy and safety study with SB204, an investigational topical nitric oxide-releasing drug for the treatment of acne vulgaris
Idowu et al. Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers following intravenous administration of enrofloxacin
Sánchez et al. Use of propolis for topical treatment of dermatophytosis in dog
Small et al. Routine measures of stress are reduced in mature channel catfish during and after AQUI‐S anesthesia and recovery
Faergemann et al. A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanism
Farfán et al. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation
Executive Committee of Guideline for the Diagnosis and Treatment of Scabies et al. Guideline for the diagnosis and treatment of scabies in Japan Executive Committee of Guideline for the Diagnosis and Treatment of Scabies
Kovalik et al. Successful treatment of idiopathic sebaceous adenitis in a lionhead rabbit
Trevisan et al. Disease behaviours of sows naturally infected with Taenia solium in Tanzania
Executive Committee of Guideline for the Diagnosis et al. Guideline for the diagnosis and treatment of scabies in Japan
Drake et al. Treatment success in three Andean bears (Tremarctos ornatus) with alopecia syndrome using oclacitinib maleate (Apoquel®)
RABBIT AEMV FORUM
Metwally et al. Biomarkers as predictive tools to test the in vivo anti-sarcoptic mange activity of propolis in naturally infested rabbits
Trüeb et al. Parasitic diseases and infestations of the hair and scalp
US9895388B1 (en) Methods and compositions useful for controlling cutaneous mites
Vaughan et al. Cryptococcosis in Gilbert's and long-nosed potoroo
Arul et al. Successful Management of Concurrent Scabies and Dermatophytosis in a Chippiparai Pup
Campbell Allergic skin diseases in dogs and cats
Mindru et al. Epidemiology and clinical presentation of dogs infected with sarcoptic mange
Stolbova et al. Change of immunological blood indicators during follicular cattle mange.
Vogelnest et al. An undescribed Demodex sp. and demodicosis in a captive koala (Phascolarctos cinereus)
Sokolova et al. Scabious erythroderma-a rare clinical variant of scabies.